A citation-based method for searching scientific literature

Jeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Mark F Bear, Paul P Wang, Randall L Carpenter. Neuropsychopharmacology 2017
Times Cited: 81







List of co-cited articles
1368 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Arbaclofen in fragile X syndrome: results of phase 3 trials.
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, Dejan Budimirovic, Walter E Kaufmann, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Paul Wang, Mark F Bear,[...]. J Neurodev Disord 2017
101
40

GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.
J L Silverman, M C Pride, J E Hayes, K R Puhger, H M Butler-Struben, S Baker, J N Crawley. Neuropsychopharmacology 2015
142
30

STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Craig A Erickson, Jeremy M Veenstra-Vanderweele, Raun D Melmed, James T McCracken, Lawrence D Ginsberg, Linmarie Sikich, Lawrence Scahill, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen,[...]. J Autism Dev Disord 2014
82
29

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Christina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, Matthew Shumway, Rebecca S Hammond, Friso R Postma, Christopher Brynczka, Roger Rush, Alexia Thomas, Richard Paylor,[...]. Sci Transl Med 2012
184
28

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
231
27

Model of autism: increased ratio of excitation/inhibition in key neural systems.
J L R Rubenstein, M M Merzenich. Genes Brain Behav 2003
27

Risperidone in children with autism and serious behavioral problems.
James T McCracken, James McGough, Bhavik Shah, Pegeen Cronin, Daniel Hong, Michael G Aman, L Eugene Arnold, Ronald Lindsay, Patricia Nash, Jill Hollway,[...]. N Engl J Med 2002
901
22

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Randall Owen, Linmarie Sikich, Ronald N Marcus, Patricia Corey-Lisle, George Manos, Robert D McQuade, William H Carson, Robert L Findling. Pediatrics 2009
345
22

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Michael G Aman, Robert L Findling, Antonio Y Hardan, Robert L Hendren, Raun D Melmed, Ola Kehinde-Nelson, Hai-An Hsu, Joel M Trugman, Robert H Palmer, Stephen M Graham,[...]. J Child Adolesc Psychopharmacol 2017
48
35

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
Ronald N Marcus, Randall Owen, Lisa Kamen, George Manos, Robert D McQuade, William H Carson, Michael G Aman. J Am Acad Child Adolesc Psychiatry 2009
323
20

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
Bryan H King, Eric Hollander, Linmarie Sikich, James T McCracken, Lawrence Scahill, Joel D Bregman, Craig L Donnelly, Evdokia Anagnostou, Kimberly Dukes, Lisa Sullivan,[...]. Arch Gen Psychiatry 2009
265
19

GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.
D Sinclair, R Featherstone, M Naschek, J Nam, A Du, S Wright, K Pance, O Melnychenko, R Weger, S Akuzawa,[...]. eNeuro 2017
54
29

R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice.
Laura J Stoppel, Tatiana M Kazdoba, Melanie D Schaffler, Anthony R Preza, Arnold Heynen, Jacqueline N Crawley, Mark F Bear. Neuropsychopharmacology 2018
50
32

R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
Mei Qin, Tianjian Huang, Michael Kader, Leland Krych, Zengyan Xia, Thomas Burlin, Zachary Zeidler, Tingrui Zhao, Carolyn B Smith. Int J Neuropsychopharmacol 2015
38
39

A randomised controlled trial of bumetanide in the treatment of autism in children.
E Lemonnier, C Degrez, M Phelep, R Tyzio, F Josse, M Grandgeorge, N Hadjikhani, Y Ben-Ari. Transl Psychiatry 2012
181
17

Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder.
Evdokia Anagnostou, Nancy Jones, Marisela Huerta, Alycia K Halladay, Paul Wang, Lawrence Scahill, Joseph P Horrigan, Connie Kasari, Cathy Lord, Dennis Choi,[...]. Autism 2015
107
16

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.
Federico Bolognani, Marta Del Valle Rubido, Lisa Squassante, Christoph Wandel, Michael Derks, Lorraine Murtagh, Jeff Sevigny, Omar Khwaja, Daniel Umbricht, Paulo Fontoura. Sci Transl Med 2019
51
25

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Elizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, Karin Rerat, Barbara Koumaras, Liansheng Zhu,[...]. Sci Transl Med 2016
166
14


Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Elizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, George Apostol, Mark F Bear, Randall L Carpenter, Jacqueline N Crawley, Aurore Curie, Vincent Des Portes, Farah Hossain,[...]. Nat Rev Drug Discov 2018
180
14

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante,[...]. Neuropsychopharmacology 2017
41
26

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Katrina Williams, Amanda Brignell, Melinda Randall, Natalie Silove, Philip Hazell. Cochrane Database Syst Rev 2013
133
13

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders.
Noha F Minshawi, Logan K Wink, Rebecca Shaffer, Martin H Plawecki, David J Posey, Hai Liu, Sarah Hurwitz, Christopher J McDougle, Naomi B Swiezy, Craig A Erickson. Mol Autism 2016
34
32

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Sarah Shea, Atilla Turgay, Alan Carroll, Miklos Schulz, Herbert Orlik, Isabel Smith, Fiona Dunbar. Pediatrics 2004
318
13

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.
Evdokia Anagnostou, Latha Soorya, William Chaplin, Jennifer Bartz, Danielle Halpern, Stacey Wasserman, A Ting Wang, Lauren Pepa, Nadia Tanel, Azadeh Kushki,[...]. Mol Autism 2012
229
13

Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
Lawrence Scahill, James T McCracken, Bryan H King, Carol Rockhill, Bhavik Shah, Laura Politte, Roy Sanders, Mendy Minjarez, Jennifer Cowen, Jennifer Mullett,[...]. Am J Psychiatry 2015
89
13

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.
Karen J Parker, Ozge Oztan, Robin A Libove, Raena D Sumiyoshi, Lisa P Jackson, Debra S Karhson, Jacqueline E Summers, Kyle E Hinman, Kara S Motonaga, Jennifer M Phillips,[...]. Proc Natl Acad Sci U S A 2017
170
13

Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yoon Phaik Ooi, Shih-Jen Weng, Joe Kossowsky, Heike Gerger, Min Sung. Pharmacopsychiatry 2017
65
16

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
Antonio Y Hardan, Lawrence K Fung, Robin A Libove, Tetyana V Obukhanych, Surekha Nair, Leonore A Herzenberg, Thomas W Frazier, Rabindra Tirouvanziam. Biol Psychiatry 2012
155
13

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
E Lemonnier, N Villeneuve, S Sonie, S Serret, A Rosier, M Roue, P Brosset, M Viellard, D Bernoux, S Rondeau,[...]. Transl Psychiatry 2017
89
13

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.
Karen J Parker, Ozge Oztan, Robin A Libove, Noreen Mohsin, Debra S Karhson, Raena D Sumiyoshi, Jacqueline E Summers, Kyle E Hinman, Kara S Motonaga, Jennifer M Phillips,[...]. Sci Transl Med 2019
66
16

Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder.
L A Ajram, J Horder, M A Mendez, A Galanopoulos, L P Brennan, R H Wichers, D M Robertson, C M Murphy, J Zinkstok, G Ivin,[...]. Transl Psychiatry 2017
67
16

Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
Oliver D Howes, Maria Rogdaki, James L Findon, Robert H Wichers, Tony Charman, Bryan H King, Eva Loth, Gráinne M McAlonan, James T McCracken, Jeremy R Parr,[...]. J Psychopharmacol 2018
105
13

Synaptic, transcriptional and chromatin genes disrupted in autism.
Silvia De Rubeis, Xin He, Arthur P Goldberg, Christopher S Poultney, Kaitlin Samocha, A Erucment Cicek, Yan Kou, Li Liu, Menachem Fromer, Susan Walker,[...]. Nature 2014
12



The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Adam J Guastella, Kylie M Gray, Nicole J Rinehart, Gail A Alvares, Bruce J Tonge, Ian B Hickie, Caroline M Keating, Cristina Cacciotti-Saija, Stewart L Einfeld. J Child Psychol Psychiatry 2015
192
12

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder.
Antony Loebel, Matthew Brams, Robert S Goldman, Robert Silva, David Hernandez, Ling Deng, Raymond Mankoski, Robert L Findling. J Autism Dev Disord 2016
43
23

A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder.
Olivia M Dean, Kylie M Gray, Kristi-Ann Villagonzalo, Seetal Dodd, Mohammadreza Mohebbi, Tanya Vick, Bruce J Tonge, Michael Berk. Aust N Z J Psychiatry 2017
30
33

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
Logan K Wink, Ryan Adams, Zemin Wang, James E Klaunig, Martin H Plawecki, David J Posey, Christopher J McDougle, Craig A Erickson. Mol Autism 2016
57
17

Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.
Sung Han, Chao Tai, Ruth E Westenbroek, Frank H Yu, Christine S Cheah, Gregory B Potter, John L Rubenstein, Todd Scheuer, Horacio O de la Iglesia, William A Catterall. Nature 2012
418
11

The contribution of de novo coding mutations to autism spectrum disorder.
Ivan Iossifov, Brian J O'Roak, Stephan J Sanders, Michael Ronemus, Niklas Krumm, Dan Levy, Holly A Stessman, Kali T Witherspoon, Laura Vives, Karynne E Patterson,[...]. Nature 2014
11

Advancing the understanding of autism disease mechanisms through genetics.
Luis de la Torre-Ubieta, Hyejung Won, Jason L Stein, Daniel H Geschwind. Nat Med 2016
447
11

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.
Eric Hollander, Latha Soorya, William Chaplin, Evdokia Anagnostou, Bonnie P Taylor, Casara J Ferretti, Stacey Wasserman, Erika Swanson, Cara Settipani. Am J Psychiatry 2012
98
11

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.
Eric Hollander, Ann Phillips, William Chaplin, Karen Zagursky, Sherie Novotny, Stacey Wasserman, Rupa Iyengar. Neuropsychopharmacology 2005
218
11

Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
H Kosaka, Y Okamoto, T Munesue, H Yamasue, K Inohara, T Fujioka, T Anme, M Orisaka, M Ishitobi, M Jung,[...]. Transl Psychiatry 2016
77
11

Sulforaphane treatment of autism spectrum disorder (ASD).
Kanwaljit Singh, Susan L Connors, Eric A Macklin, Kirby D Smith, Jed W Fahey, Paul Talalay, Andrew W Zimmerman. Proc Natl Acad Sci U S A 2014
246
11

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.
Thomas Owley, Jeff Salt, Stephen Guter, Adam Grieve, Laura Walton, Nelson Ayuyao, Bennett L Leventhal, Edwin H Cook. J Child Adolesc Psychopharmacol 2006
72
12

Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
Dae-Wook Kang, James B Adams, Ann C Gregory, Thomas Borody, Lauren Chittick, Alessio Fasano, Alexander Khoruts, Elizabeth Geis, Juan Maldonado, Sharon McDonough-Means,[...]. Microbiome 2017
597
11

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.
Hsiao-Tuan Chao, Hongmei Chen, Rodney C Samaco, Mingshan Xue, Maria Chahrour, Jong Yoo, Jeffrey L Neul, Shiaoching Gong, Hui-Chen Lu, Nathaniel Heintz,[...]. Nature 2010
815
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.